TAT Gene

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Rui Liu	+ 226 word(s)	226	2020-12-15 08:11:45	\|
2	format	Rui Liu	+ 13 word(s)	239	2020-12-24 04:53:52	\|

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/tat

Tyrosine aminotransferase: The TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase.

genes

1. Normal Function

The TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase. This enzyme is the first in a series of five enzymes that work to break down the amino acid tyrosine, a protein building block found in many foods. Specifically, tyrosine aminotransferase converts tyrosine into a byproduct called 4-hydroxyphenylpyruvate. Continuing the process, 4-hydroxyphenylpyruvate is further broken down and ultimately smaller molecules are produced that are either excreted by the kidneys or used to produce energy or make other substances in the body.

2. Health Conditions Related to Genetic Changes

2.1. Tyrosinemia

At least 22 TAT gene mutations have been found to cause tyrosinemia type II. This condition often affects the eyes, skin, and mental development. Most of these mutations change single DNA building blocks (base pairs) within the TAT gene. Research suggests that the altered TAT gene produces a tyrosine aminotransferase enzyme with reduced activity. Other mutations delete all or part of the TAT gene, eliminating enzyme activity. As a result of these mutations, tyrosine is not properly broken down. Tyrosine levels are elevated and some tyrosine is converted into other molecules that may be toxic to cells. It is unclear how impaired break down of tyrosine leads to the skin, eye, and intellectual problems that characterize tyrosinemia type II.

3. Other Names for This Gene

ATTY_HUMAN
L-tyrosine:2-oxoglutarate aminotransferase
tyrosine transaminase

References

Bouyacoub Y, Zribi H, Azzouz H, Nasrallah F, Abdelaziz RB, Kacem M, Rekaya B, Messaoud O, Romdhane L, Charfeddine C, Bouziri M, Bouziri S, Tebib N, Mokni M,Kaabachi N, Boubaker S, Abdelhak S. Novel and recurrent mutations in the TAT genein Tunisian families affected with Richner-Hanhart syndrome. Gene. 2013 Oct15;529(1):45-9. doi: 10.1016/j.gene.2013.07.066.
Mehere P, Han Q, Lemkul JA, Vavricka CJ, Robinson H, Bevan DR, Li J. Tyrosine aminotransferase: biochemical and structural properties and molecular dynamicssimulations. Protein Cell. 2010 Nov;1(11):1023-32. doi:10.1007/s13238-010-0128-5.
Sivaraman S, Kirsch JF. The narrow substrate specificity of human tyrosineaminotransferase--the enzyme deficient in tyrosinemia type II. FEBS J. 2006May;273(9):1920-9.

©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Genetics & Heredity

Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :

Rui Liu

View Times: 418

Entry Collection: MedlinePlus

Update Date: 24 Dec 2020

Table of Contents

Video Upload Options

Confirm